Search Press releases Keywords From To 10 May 2006 UCB and Immunomedics announce worldwide development collaboration and license agreement for Epratuzumab Read More 28 Apr 2006 UCB Submits Marketing Authorisation Application in Europe for CIMZIATM, a New Crohn's Disease Therapy Read More 26 Apr 2006 UCB: Two European Regulatory Milestones for Keppra® Read More 24 Apr 2006 UCB transfers back to Recordati the rights for the sale of Corifeo® (Lercanidipine) in Germany Read More 31 Mar 2006 UCB - 2005 Annual Report on-line Read More 31 Mar 2006 UCB - 2005 Annual Report on-line Read More Pagination First page Previous page Previous … Page 184 Page 185 Page 186 Page 187 Current page 188 Page 189 Page 190 Page 191 Page 192 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
